Читать книгу Cases in Medical Microbiology and Infectious Diseases - Melissa B. Miller - Страница 46

1. Bolan GA, Sparling PF, Wasserheit JN. 2012. The emerging threat of untreatable gonococcal infection. N Engl J Med 366:485–487.

2. Burstein GR, Gaydos CA, Diener-West M, Howell MR, Zenilman JM, Quinn TC. 1998. Incident Chlamydia trachomatis infections among inner-city adolescent females. JAMA 280:521–526.

3. Centers for Disease Control and Prevention (CDC). 1999. High prevalence of chlamydial and gonococcal infection in women entering jails and juvenile detention centers—Chicago, Birmingham, and San Francisco, 1998. MMWR Morb Mortal Wkly Rep 48:793–796.

4. Centers for Disease Control and Prevention (CDC). 2012. Update to CDC’s Sexually Transmitted Diseases Treatment Guidelines, 2010: oral cephalosporins no longer a recommended treatment for gonococcal infections. MMWR Morb Mortal Wkly Rep 10:590–594.

5. Katz AR, Effler PV, Ohye RG, Brouillet B, Lee MV, Whiticar PM. 2004. False-positive gonorrhea test results with a nucleic acid amplification test: the impact of low prevalence on positive predictive value. Clin Infect Dis 38:814–819.

6. Scholes D, Stergachis A, Heidrich FE, Andrilla H, Holmes KK, Stamm WE. 1996. Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection. N Engl J Med 334:1362–1366.

7. Workowski KA, Berman S; Centers for Disease Control and Prevention (CDC). 2010. Sexually transmitted diseases treatment guidelines. MMWR Recomm Rep 59:1–116.